Thor Medical Stock Nasdaq Stockholm
Stocks
NANOVO
NO0010597883
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Nasdaq Stockholm
20:00:00 15/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 4.360 NOK | -2.35% |
|
-0.89% | -12.62% |
| 10-07 | Thor Medical ASA Opens AlphaOne Production Facility At Herøya Industrial Park | CI |
| 09-21 | Thor Medical ASA(OB:TRMED) added to S&P Global BMI Index | CI |
| Market Cap | 1.87B 197M 176M 163M 149M 279M 18.65B 285M 1.96B 768M 9.73B 739M 723M 31.13B | P/E 2026 * |
-24.6x | P/E 2027 * | -44.2x |
|---|---|---|---|---|---|
| Enterprise Value | 2.06B 218M 194M 181M 164M 309M 20.61B 315M 2.17B 849M 10.75B 817M 799M 34.41B | EV / Sales 2026 * |
103x | EV / Sales 2027 * | 14.3x |
| Free-Float |
75.21% | Yield 2026 * |
-
| Yield 2027 * | - |
Nasdaq StockholmNOK
| Markets | Quality | ||
|---|---|---|---|
Oslo Bors
| NANOV | Real-time | |
CBOE
| NANOo | Real-time | |
|
London S.E.
| 0R6Y | End-of-day quote | |
|
Tradegate
| 8NN | Real-time | |
|
Nasdaq Stockholm
| NANOVO | Delayed | |
|
Deutsche Boerse AG
| 8NN | Delayed | |
|
London S.E.
| 0R6Y | Delayed | |
|
CBOE
| 0R6Y | Real-time | |
|
Börse Stuttgart
| 8NN | Delayed | |
|
Boerse Muenchen
| 8NN | Real-time | |
|
Berne S.E.
| 8NN | End-of-day quote |
Last Transcript: Thor Medical
| Current month | -3.22% | ||
| 1 month | -9.26% | ||
| 6 months | -12.45% | ||
| Current year | -14.68% |
| 1 month | 4.36 |  | 4.72 |
| 3 years | 1.05 | | 7.11 |
| 5 years | 1.05 | | 28.72 |
| 10 years | 1.05 | | 125 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jasper Kurth
CEO | Chief Executive Officer | 41 | 01/08/2024 |
| Director of Finance/CFO | 37 | 01/07/2023 | |
Sindre Hassfjell
CTO | Chief Tech/Sci/R&D Officer | - | 01/06/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 67 | 28/06/2023 | |
John Andersen
CHM | Chairman | 59 | - |
| Director/Board Member | - | 24/04/2025 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.35% | -0.89% | +25.11% | +123.59% | 196M | |
| +0.21% | -7.67% | +61.07% | +71.32% | 68.92B | |
| +1.66% | +7.51% | +8.12% | +61.40% | 51.9B | |
| +3.14% | +7.17% | +12.48% | +41.70% | 48.73B | |
| +3.17% | +4.30% | +32.93% | +35.69% | 43.13B | |
| -1.13% | +1.73% | +286.16% | +460.90% | 41.48B | |
| +5.67% | +6.15% | +17.56% | +113.68% | 39.96B | |
| +1.28% | -0.76% | +12.67% | +45.10% | 30.6B | |
| -2.21% | -14.22% | +40.33% | -0.94% | 26.01B | |
| +2.20% | -1.81% | -13.37% | -6.79% | 22.27B | |
| Average | +1.55% | -3.90% | +48.31% | +94.57% | 41.44B | |
| Weighted average by Cap. | +1.60% | -3.49% | +54.59% | +97.97% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 20M 2.11M 1.88M 1.75M 1.59M 2.99M 200M 3.05M 21.01M 8.22M 104M 7.91M 7.74M 333M | 145M 15.28M 13.64M 12.68M 11.53M 21.7M 1.45B 22.09M 152M 59.6M 755M 57.36M 56.14M 2.42B |
| Net income | -70M -7.38M -6.59M -6.12M -5.57M -10.48M -699M -10.66M -73.53M -28.77M -365M -27.69M -27.1M -1.17B | -44M -4.64M -4.14M -3.85M -3.5M -6.58M -439M -6.7M -46.22M -18.08M -229M -17.41M -17.04M -733M |
| Net Debt | 197M 20.77M 18.54M 17.23M 15.67M 29.48M 1.97B 30.01M 207M 80.97M 1.03B 77.93M 76.28M 3.28B | 201M 21.19M 18.91M 17.58M 15.99M 30.08M 2.01B 30.62M 211M 82.61M 1.05B 79.51M 77.83M 3.35B |
Employees
-
| Date | Price | Change |
|---|---|---|
| 15/10/26 | NOK 4.360 | -2.35% |
Sell
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
4.420NOK
Average target price
4.200NOK
Spread / Average Target
-4.98%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- NANOV Stock
- NANOVO Stock
Select your edition
All financial news and data tailored to specific country editions
